4//SEC Filing
Bernstein Joel E. 4
Accession 0001209191-09-021628
CIK 0001302554other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 5:25 PM ET
Size
5.9 KB
Accession
0001209191-09-021628
Insider Transaction Report
Form 4
Bernstein Joel E.
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock Options
2009-04-07+100,000→ 100,000 totalExercise: $1.53Exp: 2019-04-07→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Such options vest in five equal annual installments, commencing 04/07/2010.
- [F2]Reported amount excludes options to purchase 661,913 shares of the Company's common stock, initially exercisable on 04/06/2006 and expiring on 04/06/2010, at an exercise price of $0.37.
Documents
Issuer
Winston Pharmaceuticals, Inc.
CIK 0001302554
Entity typeother
Related Parties
1- filerCIK 0001447384
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 5:25 PM ET
- Size
- 5.9 KB